HOME >> MEDICINE >> NEWS
UCLA/VA research analysis in journal Nature explains wide variations in animal sleep habits

An extensive research analysis by a neuroscientist at UCLA's Semel Institute and the Veterans Affairs' Neurobiology Research Laboratory concludes that environment and diet largely determine sleep needs.

Appearing in the Oct. 27 edition of the peer-reviewed journal Nature, the analysis shows that meat-eating species sleep the most and grazing animals the least. Sleep amounts range from 20 hours in the little brown bat to only two hours in the horse. Animals that have less sleep do not appear to make up for this by sleeping more deeply.

The analysis concludes that sleep functions to keep animals safe by restricting waking to the hours when an animal is most likely to be successful at finding food and avoiding danger.

Human sleep follows the rules that determine sleep time in other animals, the analysis concludes. Humans sleep somewhat less than animals with similar physiological features, suggesting that we may have evolved to have more waking hours in order to better compete with other humans.

"Conventional wisdom in much of neuroscience has been that sleep has a single vital function across animals, just as food and water have universal functions," said Dr. Jerome Siegel, professor-in-residence at the UCLA Neuropsychiatric Institute and chief of neurobiology research at the VA Greater Los Angeles Healthcare System, Sepulveda.

"Yet some animals can go without sleep for long periods of time with no ill effects, whereas sleep deprivation in others can be lethal," Siegel said. "These new conclusions explain why some animals can survive and reproduce optimally with only a few waking hours, whereas others need to eat all day and must have reduced sleep time."


'"/>

Contact: Dan Page
dpage@mednet.ucla.edu
310-794-2265
University of California - Los Angeles
26-Oct-2005


Page: 1

Related medicine news :

1. UCLA/VA study: Many patients not receiving follow-up tests after positive screening for colon cancer
2. 1 of 2 pediatric kidney disease research centers in world established
3. Stanford researchers find culprit in aging muscles that heal poorly
4. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
5. Indiana University Imaging Center receives $6M grant for kidney research
6. Penn researchers discover novel pathway for increasing good cholesterol
7. New research discovers independent brain networks control human walking
8. Theory of facial aging gets a facelift from UT Southwestern researchers
9. Sports concussion research using fMRI provides insight for safe return-to-play decisions
10. UIC researchers to develop new drugs to fight bioterrorism
11. New research finds high prevalence of smoking among physicians in China

Post Your Comments:
(Date:1/22/2015)... January 23, 2015 LunaDress, with its top ... fashion industry. Now, the business is showing its latest designs ... dresses. , According to the company’s CEO, all the fresh ... offered with big discounts, up to 80% off. All the ...
(Date:1/22/2015)... January 22, 2015 Padre Murphy's and Owner ... of Pro Player Health Alliance (PPHA). The PPHA's ... in getting everyone, including NFL greats, treated for obstructive sleep ... leading groups supporting the cause in the valley. The most ...
(Date:1/22/2015)... January 22, 2015 Blue Cross and Blue ... who exemplify what it means to “Live Fearless.” ... people to share their stories about how they or someone ... inspired others by living in the moment. By telling these ...
(Date:1/22/2015)... A new white paper by The ... in the long-term care environment as well as provides ... The paper, “The Power of Person-Centeredness in Long-Term Care: ... of the patient, resident and family experience in long-term ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
(Date:1/23/2015)... , Jan. 23, 2015  Immune Therapeutics, Inc. today announced the ... the compounding, packaging and distributing of its naltrexone tablets.  The ... United States . KRS Global is ... tablets in various strengths for individual patients in response to ...
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
(Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: